Evaluation of Fertitonex Effects on Semen Parameters in Clinical Varicocele Patient.

Launched by MENOUFIA UNIVERSITY · Dec 4, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a treatment called Fertitonex on men who have a condition known as varicocele, which can affect their fertility. The researchers want to see if Fertitonex can improve sperm health in men who have primary infertility and abnormal semen tests, along with a confirmed case of varicocele.

To be eligible for this trial, participants need to be men aged 65 to 74 who have been diagnosed with primary infertility and have abnormal results from their semen analysis. The trial is currently looking for volunteers, and it’s important to note that men who have had previous surgeries for varicocele or who have normal semen analysis results will not qualify. Participants in this trial can expect to receive the treatment and be monitored for changes in their semen parameters, helping to determine if Fertitonex could be a beneficial option for improving fertility in men with varicocele.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Primary infertility.
• • Abnormal semen analysis parameters.
• • Clinically evident varicocele confirmed by scrotal duplex.
• Exclusion Criteria:
• • 2ry infertility.
• • Normal semen analysis parameters.
• • Clinically non-evident varicocele.
• • Past history of varicocelectomy.